Identification of key vaginal microbial signatures and immune remodeling associated with HR-HPV clearance following Kushen Gel treatment: a longitudinal analysis.
Wang Ying Y, Pan Shuheng S, Zhang Fengying F, Ma Huimin H et al.
Persistent high-risk human papillomavirus (HR-HPV) infection drives cervical carcinogenesis, often exacerbated by vaginal dysbiosis and localized immune dysfunction. Kushen Gel shows clinical promise, yet its impact on microbial-immune crosstalk during HR-HPV clearance remains unclear. This study elucidates the microbial remodeling and immune shifts associated with Kushen Gel-mediated HR-HPV regression. A retrospective analysis of 230 vaginal swabs (130 pre-treatment, 100 post-treatment) via 16S rRNA sequencing characterized community structural shifts. Subsequently, a prospective cohort of 35 patients with persistent HR-HPV infection (defined as laboratory-confirmed positive HR-HPV DNA for ≥12 months) validated clinical outcomes (HR-HPV clearance, vaginal pH, Nugent scores) alongside paired 16S rRNA sequencing and ELISA-based quantification of cervicovaginal cytokines (IL-8, IL-6, TNF-α, IFN-γ). Kushen Gel intervention significantly decreased microbial alpha diversity and was associated with a distinct beta-diversity shift toward a stable, Lactobacillus-dominant state. Models (LEfSe, Random Forest) identified a marked reduction in pathobionts (Gardnerella, Sneathia, Prevotella) post-treatment. In the prospective cohort, the HR-HPV clearance rate reached 82.9% (29/35) after three menstrual cycles, synchronized with significant reductions in mean vaginal pH (4.85 ± 0.42 to 4.12 ± 0.35, p < 0.001) and an 85.7% Nugent score normalization rate. Crucially, Kushen Gel treatment was associated with a profound shift from a pro-inflammatory to an anti-viral immune microenvironment. Pro-inflammatory markers (IL-8, IL-6, TNF-α) plummeted significantly (p < 0.0001), while anti-viral IFN-γ exhibited a robust increase (3.2 ± 1.1 to 18.6 ± 5.4 pg./mL, p < 0.0001), particularly in responders. Lactobacillus abundance positively correlated with IFN-γ (r = 0.68) and inversely with IL-8 (r = -0.54). Kushen Gel is associated with HR-HPV clearance and concurrent vaginal microenvironment remodeling, marked by suppressed anaerobic-driven inflammation and an enhanced IFN-γ-associated anti-viral niche dominated by Lactobacillus. These findings biologically support using Kushen Gel to manage vaginal dysbiosis and HR-HPV regression.